Ying Lu

10PUBLICATIONS
41CO-AUTHORS
Cancer geneticsTumour immunologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Oct 13, 2026
A Germline-Encoded lncRNA-Mitochondrial Axis Rewires Oxidative Phosphorylation to Drive Progression in Clear Cell Renal Cell Carcinoma.

|Aug 22, 2025
Targeting MondoA-TXNIP restores antitumour immunity in lactic-acid-induced immunosuppressive microenvironment.

Nannan Xu, Yemin Zhu, Yichao Han

|Dec 22, 2024
Dura immunity configures leptomeningeal metastasis immunosuppression for cerebrospinal fluid barrier invasion.

Jiaxu Zhao, Rui Zeng, Xiaohui Li

|Apr 26, 2024
From biology to the clinic - exploring liver metastasis in prostate cancer.

Xudong Ni, Yu Wei, Xiaomeng Li

|Apr 02, 2024
Targeting the tumor microenvironment, a new therapeutic approach for prostate cancer.

Bangwei Fang, Ying Lu, Xiaomeng Li

|May 23, 2022
Non-oxidative pentose phosphate pathway controls regulatory T cell function by integrating metabolism and epigenetics.

Qi Liu, Fangming Zhu, Xinnan Liu

Pageof 2

Frequent Collaborators

6 joint publications

Xuemei Tong

5 joint publications

Bin Li

3 joint publications

Yichao Han

2 joint publications

Jianli He